Annual Report 2007 - Index

  •  
  •  
  •  
  •  
  • Healthcare Professionals
  •  
  • Patients
  •  
  • Investors
  •  
  • Media
  •  
  • R&D
  •  
  • Jobs
  •  
  • Sustainability
  •  
  • About us
  • How we manage sustainably
  • Our positions
  • Our priorities
  • Our reporting
  • News on progress
  • Try our interactive challenges
  • Get in touch
  • Rate this page
  • Send to a friend
  • Print

Quickguide index

Are you looking for specific information and do not immediately find it, this index might be of help:

Topic of interest

A
About Novo Nordisk
Access to health
Accountability
Advocacy
Animal welfare
Audit and assurance
Awards and recognitions
B
Biopharmaceuticals
Board of Directors
Brand and reputation management
Business ethics
Business strategy
C
Capital structure
Changing diabetes
Climate change
Clinical trials
Community engagement
Compliance
Corporate governance
D
Definitions
Diabetes care
Diversity
Donations
E
Economic footprint
Environment
Executive Management
F
Financial performance
G
Gene technology
Global Compact
GRI
H
Health and safety
Human rights
L
Legal issues
M
Materiality
Memberships
N
Novo Nordisk Way
P
Partnerships
People strategy
Pipeline
Product stewardship
Q
Quality
R
Remuneration
Responsible sourcing
Risk management
S
Social responsibility
Socio-economics
Share information
Stakeholder engagement
Stem cell research
Sustainability
T
Talent development
Tax
Triple Bottom Line
W
Workplace quality

 

Back to top
 
  • Novo Nordisk in the USA
  • Novo Nordisk in Denmark
  • Novo Nordisk around the world
  • Disclaimer/Privacy
  • © Novo Nordisk A/S 2009